214 related articles for article (PubMed ID: 28097621)
1. Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.
Betthauser K; Pope H; Gowan M; Human T
Neurocrit Care; 2017 Aug; 27(1):96-102. PubMed ID: 28097621
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients.
Lee YR; Blanco DD
J Thromb Thrombolysis; 2017 Oct; 44(3):386-391. PubMed ID: 28828713
[TBL] [Abstract][Full Text] [Related]
3. Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill.
Carter C; Bushwitz J; Gowan M; Pope H; Human T; Gibson G; Owen E; Hampton N; Whitman C
Ann Pharmacother; 2016 Oct; 50(10):832-9. PubMed ID: 27371544
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
6. A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.
Stelfox HT; Brundin-Mather R; Soo A; Parsons Leigh J; Niven DJ; Fiest KM; Doig CJ; Zuege DJ; Kushner B; Clement F; Straus SE; Cook DJ; Bagshaw SM; Sauro KM
Intensive Care Med; 2019 Feb; 45(2):211-222. PubMed ID: 30707246
[TBL] [Abstract][Full Text] [Related]
7. Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients.
Laporte S; Liotier J; Bertoletti L; Kleber FX; Pineo GF; Chapelle C; Moulin N; Mismetti P
J Thromb Haemost; 2011 Mar; 9(3):464-72. PubMed ID: 21232002
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.
Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Venous Thromboembolism Prophylactic Measures Post Coronary Artery Bypass Graft Surgery.
Wilsey HA; Pandya K; Beavers C; Xiaoshu L; Ather A
Am J Cardiovasc Drugs; 2019 Dec; 19(6):589-595. PubMed ID: 31203501
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients.
DeBiase C; Giuliano CA; Doshi M; Ganoff M; Alexander Paxton R
Pharmacotherapy; 2021 May; 41(5):424-429. PubMed ID: 33641194
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
[TBL] [Abstract][Full Text] [Related]
12. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.
Samuel S; Li W; Dunn K; Cortes J; Nguyen T; Moussa D; Kumar A; Dao T; Beeson J; Choi HA; McCullough LD
J Thromb Thrombolysis; 2023 May; 55(4):617-625. PubMed ID: 37029256
[TBL] [Abstract][Full Text] [Related]
13. Venous Thromboembolism Prophylaxis in Low Body Weight Critically Ill Patients.
Knox H; Edwin SB; Giuliano C; Paxton RA
J Intensive Care Med; 2024 May; 39(5):493-498. PubMed ID: 38111295
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis.
Bushwitz J; LeClaire A; He J; Mozingo D
J Burn Care Res; 2011; 32(6):578-82. PubMed ID: 21841495
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients.
Buckheit D; Lefemine A; Sobieraj DM; Hobbs L
Clin Appl Thromb Hemost; 2021; 27():10760296211018752. PubMed ID: 34080451
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose versus Therapeutic Range Intravenous Unfractionated Heparin Prophylaxis in the Treatment of Patients with Severe Aneurysmal Subarachnoid Hemorrhage After Aneurysm Occlusion.
Kunz M; Siller S; Nell C; Schniepp R; Dorn F; Huge V; Tonn JC; Pfister HW; Schichor C
World Neurosurg; 2018 Sep; 117():e705-e711. PubMed ID: 29959066
[TBL] [Abstract][Full Text] [Related]
18. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of High-Dose Unfractionated Heparin for Prevention of Venous Thromboembolism in Overweight and Obese Patients.
Joy M; Tharp E; Hartman H; Schepcoff S; Cortes J; Sieg A; Mariski M; Lee Y; Murphy M; Ranjbar G; Sharaf S; Yau G; Choi HA; Samuel S
Pharmacotherapy; 2016 Jul; 36(7):740-8. PubMed ID: 27265806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]